NASDAQ:EARS
Delisted
Auris Medical Holding AG Stock News
$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022
Auris Medical Announces Launch of New Corporate Website
09:00am, Friday, 16'th Jul 2021
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,
5 Reddit Penny Stocks to Watch That Are Moving Right Now
03:58pm, Wednesday, 14'th Jul 2021
Are these Reddit penny stocks worth adding to your small-caps watchlist right now? The post 5 Reddit Penny Stocks to Watch That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, News
Auris Medical's Bentrio Nasal Spray Shows Encouraging Preclinical Action In Prevention, Mitigation Of COVID-19
11:40am, Wednesday, 14'th Jul 2021
Auris Medical Holding Ltd (NASDAQ: EARS) has announced additional preclinical data in a primary human nasal airway epithelium model from its Bentrio (AM-301) nasal spray for COVID-19. AM-301 was fo
Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2
09:00am, Wednesday, 14'th Jul 2021
Hamilton, Bermuda, July 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,
Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany
08:30am, Monday, 28'th Jun 2021
Hamilton, Bermuda, June 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,
EARS Stock Price Increases Over 14% Pre-Market
09:28am, Monday, 21'st Jun 2021
The stock price of Auris Medical Holding Ltd. (NASDAQ: EARS) increased by over 14% pre-market.
Auris Medical Enters RNA Therapeutics with Trasir Therapeutics Acquisition; Plans To Spin-Off/Divest Existing Programs
09:17am, Thursday, 03'rd Jun 2021
Auris Medical Holding Ltd (NASDAQ: EARS) has acquired privately-held Trasir Therapeutics Inc, focused on extrahepatic oligonucleotide delivery. The purchase price comprises 0.77 million common shar
EARS Stock Price: Over 9% Increase Pre-Market Explanation
08:51am, Thursday, 03'rd Jun 2021
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by over 9% pre-market. This is why it happened.
Auris Medical Holding to Present at LD Micro Invitational XI Conference
08:30am, Friday, 28'th May 2021
Hamilton, Bermuda, May 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,
Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo
08:30am, Friday, 14'th May 2021
Hamilton, Bermuda, May 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,
4 Meme Penny Stocks To Watch As DogeCoin Rises
07:16pm, Saturday, 08'th May 2021
Meme penny stocks are a budding sector; have you heard of these 4? The post 4 Meme Penny Stocks To Watch As DogeCoin Rises appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Auris Medical Stock Is Trading Higher As Bentrio Hit Primary Endpoint Goal In Allergic Rhinitis Study
03:01pm, Friday, 07'th May 2021
Auris Medical Holding Ltd (NASDAQ: EARS) has announced additional information regarding the results from the clinical trial of its nasal spray, Bentrio, meant for treating people suffering from al
EARS Stock: Over 30% Increase Intraday Explanation
10:43am, Friday, 07'th May 2021
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by over 30% during intraday trading. This is why it happened.
Auris Medical Provides Update on Bentrio Program in Allergy
09:05am, Friday, 07'th May 2021
Hamilton, Bermuda, May 7, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, r
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
07:45am, Tuesday, 13'th Apr 2021
Hamilton, Bermuda, April 13, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology
